Skip to main content
Kolinpharma logo

Kolinpharma — Investor Relations & Filings

Ticker · KIP ISIN · IT0005322950 LEI · 815600FC8F1A3BED2743 XMIL Manufacturing
Open in API
Filings indexed 222 across all filing types
Latest filing 2022-06-16 Transaction in Own Shar…
Country IT Italy
Listing XMIL KIP

About Kolinpharma

https://www.kolinpharma.com/index-en

Kolinpharma is a nutraceutical company established in 2013, specializing in the research and development of innovative products designed to improve well-being and quality of life. The company's core activities are centered on scientific research and product innovation, creating high-quality nutraceuticals. It operates an in-house R&D department and collaborates with leading universities for in-vitro and clinical studies. As a certified B Corporation, Kolinpharma adheres to high standards of social and environmental performance. The company distributes its proprietary branded products through a qualified network of medical-scientific representatives.

Recent filings

Filing Released Lang Actions
Kolinpharma, acquisto azioni proprie
Transaction in Own Shares Classification · 1% confidence The document is titled 'Comunicazione sullo stato di attuazione del Programma di ri-acquisto azioni proprie' (Communication on the status of implementation of the Share Repurchase Program) and specifically covers the period '6-10 giugno 2022'. The subject line is 'Kolinpharma, acquisto azioni proprie' (Kolinpharma, purchase of own shares). This clearly indicates a report on the company's transactions involving its own shares (share buybacks). According to the definitions, 'Transaction in Own Shares (Code: POS)' covers 'Report of the company buying back or selling its own shares (share repurchase/issuance)'. Although the document mentions 'vedi allegato' (see attachment) and is relatively short (under 5,000 characters), the core content is the mandatory disclosure of the buyback status, making POS a more specific fit than the general RPA or RNS. The content is the report itself, not just an announcement that a report exists.
2022-06-16 Italian
Kolinpharma, schema riepilogo operazioni mensili su buy-back
Transaction in Own Shares Classification · 1% confidence The document is titled 'SCHEMA DI COMUNICAZIONE DELLE OPERAZIONI SUI TITOLI DELL'EMITTENTE' (Disclosure Form for Transactions in the Issuer's Securities) and contains detailed tables reporting daily transactions (Data Operazioni, Quantità, Prezzo Medio Ponderato) for the period 02/05/2022 to 31/05/2022. The subject line mentions 'mensili su buy-back' (monthly on buy-back). This structure precisely matches the reporting requirements for a company transacting in its own shares, which corresponds to the 'Transaction in Own Shares' category. The specific code for this is POS.
2022-06-06 Italian
Kolinpharma, acquisto azioni proprie
Transaction in Own Shares Classification · 1% confidence The document is titled 'COMUNICATO STAMPA PRICE SENSITIVE' and the subject ('Oggetto') is 'Kolinpharma, acquisto azioni proprie' (Kolinpharma, purchase of own shares). The content details the execution of a share repurchase program ('Programma di acquisto azioni proprie') for the period May 30 to June 3, 2022, including the number of shares bought and the total consideration. This activity directly relates to the company managing its own stock holdings, which falls under the definition of 'Transaction in Own Shares'. The code for this is POS.
2022-06-06 Italian
Kolinpharma, acquisto azioni proprie
Transaction in Own Shares Classification · 1% confidence The document is titled "Comunicazione sullo stato di attuazione del Programma di acquisto azioni proprie" (Communication on the status of implementation of the Share Buyback Program) and details the purchase of 1,000 own shares during the period May 23-27, 2022. The subject line explicitly states "Kolinpharma, acquisto azioni proprie" (Kolinpharma, purchase of own shares). This activity directly corresponds to the definition of a company reporting transactions involving its own shares, which maps precisely to the 'Transaction in Own Shares' category (POS). It is not a general earnings release (ER), an interim report (IR), or a proxy statement (PSI).
2022-05-30 Italian
KOLINPHARMA, acquisto azioni proprie
Transaction in Own Shares Classification · 1% confidence The document is titled 'Comunicazione sullo stato di attuazione del Programma di acquisto azioni proprie' (Communication on the status of implementation of the Share Buyback Program) and explicitly details the purchase of 1,000 own shares ('acquisto azioni proprie') during the period May 16-20, 2022. This activity—the company buying back its own shares—directly corresponds to the definition of 'Transaction in Own Shares' (POS). Although it is a price-sensitive press release, the core subject matter is the share repurchase activity itself, making POS the most specific classification over a general Regulatory Filing (RNS) or Report Publication Announcement (RPA), especially since the document contains the full details rather than just announcing an attachment.
2022-05-23 Italian
KOLINPHARMA, acquisto azioni proprie
Transaction in Own Shares Classification · 1% confidence The document is titled 'COMUNICATO STAMPA PRICE SENSITIVE' and the subject is 'KOLINPHARMA, acquisto azioni proprie' (KOLINPHARMA, purchase of own shares). It details the execution of a share repurchase program for the period May 9 - May 13, 2022, including the number of shares bought and the total value. This activity—the company buying back its own shares—directly corresponds to the definition of 'Transaction in Own Shares'. The code for this is POS.
2022-05-13 Italian

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.